PriceTargets.com logo

Arkema - ARKAY Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $104.00
  • Forecasted Upside: 5.64%
  • Number of Analysts: 8
  • Breakdown:
  • 2 Sell Ratings
  • 2 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$98.45 As of 03/31/2023 01:00 AM ET
▲ +0.1 (0.10%)

This chart shows the closing price for ARKAY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Arkema Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ARKAY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ARKAY

Analyst Price Target is $104.00
▲ +5.64% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Arkema in the last 3 months. The average price target is $104.00, with a high forecast of $126.00 and a low forecast of $79.00. The average price target represents a 5.64% upside from the last price of $98.45.

This chart shows the closing price for ARKAY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 8 investment analysts is to hold stock in Arkema. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 5 buy ratings
  • 6 hold ratings
  • 2 sell ratings
Ratings as of
10/8/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 5 hold ratings
  • 2 sell ratings
Ratings as of
1/6/2022
  • 0 strong buy ratings
  • 6 buy ratings
  • 4 hold ratings
  • 2 sell ratings
Ratings as of
4/6/2022
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 2 sell ratings
Ratings as of
7/5/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 2 sell ratings
Ratings as of
10/3/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 2 sell ratings
Ratings as of
1/1/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 2 sell ratings
Ratings as of
3/2/2023
  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 2 sell ratings
Ratings as of
4/1/2023

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 2 hold ratings
  • 2 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/6/2023UBS GroupUpgradeSell ➝ Neutral
3/2/2023The Goldman Sachs GroupUpgradeNeutral ➝ Buy
1/13/2023Stifel NicolausDowngradeBuy ➝ Hold
11/22/2022Berenberg BankLower TargetBuy ➝ Buy€100.00 ➝ €98.00
11/16/2022Credit Suisse GroupLower Target€80.00 ➝ €79.00
11/14/2022BarclaysLower Target€131.00 ➝ €126.00
10/10/2022Berenberg BankLower Target€131.00 ➝ €100.00
10/5/2022Morgan StanleyLower TargetUnderweight ➝ Underweight€91.00 ➝ €88.00
10/4/2022Deutsche Bank AktiengesellschaftLower TargetBuy ➝ Buy€120.00 ➝ €110.00
9/9/2022Deutsche Bank AktiengesellschaftLower Target€135.00 ➝ €120.00
9/1/2022The Goldman Sachs GroupDowngradeBuy ➝ Neutral
8/24/2022Credit Suisse GroupReiterated RatingOutperform
7/20/2022Credit Suisse GroupLower TargetUnderperform ➝ Underperform€103.00 ➝ €87.00
7/18/2022Morgan StanleyLower TargetUnderweight ➝ Underweight€105.00 ➝ €91.00
7/14/2022BarclaysBoost Target€129.00 ➝ €131.00
7/14/2022UBS GroupDowngradeNeutral ➝ Sell
7/12/2022JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight
7/6/2022Stifel NicolausLower TargetBuy ➝ Buy€139.00 ➝ €123.00
7/5/2022Deutsche Bank AktiengesellschaftLower Target€145.00 ➝ €135.00
4/8/2022Credit Suisse GroupBoost Target€101.00 ➝ €103.00
3/30/2022Kepler Capital MarketsDowngradeBuy ➝ Hold
2/25/2022The Goldman Sachs GroupBoost Target€145.00 ➝ €146.00
2/25/2022JPMorgan Chase & Co.Boost Target€136.00 ➝ €142.00
2/4/2022BarclaysBoost Target€124.00 ➝ €129.00
1/21/2022JPMorgan Chase & Co.Boost Target€134.00 ➝ €136.00
12/13/2021Morgan StanleyDowngradeEqual Weight ➝ Underweight
12/8/2021UBS GroupLower TargetNeutral ➝ Neutral€123.00 ➝ €120.00
12/7/2021JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral
11/11/2021JPMorgan Chase & Co.Reiterated RatingOverweight
11/11/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
10/14/2021Morgan StanleyReiterated RatingEqual Weight
10/14/2021Jefferies Financial GroupInitiated CoverageBuy
10/13/2021UBS GroupReiterated RatingNeutral
9/7/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
9/3/2021CitigroupInitiated CoverageBuy
9/3/2021HSBCUpgradeHold ➝ Buy
8/19/2021Morgan StanleyReiterated RatingEqual Weight
8/13/2021JPMorgan Chase & Co.Reiterated RatingOverweight
7/30/2021Credit Suisse GroupReiterated RatingUnderperform
7/14/2021UBS GroupReiterated RatingNeutral
7/12/2021Credit Suisse GroupSet TargetUnderperform$126.72
7/7/2021BarclaysReiterated RatingEqual Weight
7/2/2021JPMorgan Chase & Co.Reiterated RatingOverweight
6/10/2021Redburn PartnersUpgradeSell ➝ Neutral
5/18/2021BarclaysReiterated RatingEqual Weight
5/12/2021Credit Suisse GroupReiterated RatingUnderperform
5/11/2021Berenberg BankReiterated RatingHold
5/7/2021JPMorgan Chase & Co.Reiterated RatingOverweight
5/7/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
4/30/2021BarclaysReiterated RatingEqual Weight
4/14/2021UBS GroupReiterated RatingNeutral
4/12/2021JPMorgan Chase & Co.Reiterated RatingOverweight
3/9/2021Stifel NicolausUpgradeHold ➝ Buy
3/3/2021Berenberg BankReiterated RatingHold
3/1/2021Kepler Capital MarketsUpgradeHold ➝ Buy
2/2/2021Redburn PartnersDowngradeBuy ➝ Sell
1/26/2021Credit Suisse GroupDowngradeOutperform ➝ Underperform
12/18/2020Societe GeneraleReiterated RatingHold
12/8/2020UBS GroupReiterated RatingNeutral
12/7/2020BarclaysReiterated RatingEqual Weight
12/7/2020Morgan StanleyDowngradeOverweight ➝ Equal Weight
11/6/2020Credit Suisse GroupReiterated RatingOutperform
10/6/2020Morgan StanleyReiterated RatingOverweight
10/5/2020Deutsche Bank AktiengesellschaftReiterated RatingBuy
9/22/2020CitigroupReiterated RatingBuy
8/14/2020HSBCDowngradeBuy ➝ Hold
8/4/2020JPMorgan Chase & Co.Reiterated RatingOverweight
8/3/2020UBS GroupReiterated RatingNeutral
7/13/2020Morgan StanleyReiterated RatingOverweight
7/8/2020UBS GroupReiterated RatingNeutral
6/19/2020Credit Suisse GroupReiterated RatingOutperform
6/1/2020UBS GroupReiterated RatingNeutral
3/30/2020Morgan StanleyReiterated RatingOverweight
3/24/2020JPMorgan Chase & Co.Reiterated RatingOverweight
3/4/2020The Goldman Sachs GroupUpgradeSell ➝ Buy
2/25/2020JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight
2/4/2020Kepler Capital MarketsUpgradeReduce ➝ Hold
1/16/2020BarclaysDowngradeOverweight ➝ Equal Weight
4/3/2019Berenberg BankInitiated CoverageHold
1/17/2019Credit Suisse GroupUpgradeNeutral ➝ Outperform
11/29/2018MacquarieInitiated CoverageOutperform ➝ Outperform
11/19/2018The Goldman Sachs GroupDowngradeNeutral ➝ Sell
11/7/2018Credit Suisse GroupUpgradeHold
(Data available from 4/1/2018 forward)

News Sentiment Rating

0.54 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/3/2022
  • 3 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/3/2022
  • 3 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/2/2022
  • 2 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
12/2/2022
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/1/2023
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/31/2023
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/2/2023
  • 2 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/1/2023

Current Sentiment

  • 2 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Arkema logo
Arkema SA engages in manufacturing and supply of chemical products. It operates through followings segments: High Performance Materials, Industrials Specialties, and Coating Solutions. The High Performance Materials segment includes the Technical Polymers, Filtration and Adsorption and Organic Peroxides business units and provides solutions with high value added, used in varied sectors such as transportation, oil extraction, renewable energies, consumer goods, electronics, construction, coatings, and water treatment. The Industrials Specialties segment groups the following business units: thiochemicals, fluorochemicals, polymethyl methacrylate, and hydrogen peroxides. The Coating Solutions segment proposes solutions for decorative paints, industrial coatings, adhesives, and high-growth acrylic applications. The company was founded on January 31, 2003 and is headquartered in Colombes, France.
Read More

Today's Range

Now: $98.45
Low: $98.39
High: $98.92

50 Day Range

MA: $99.90
Low: $94.27
High: $105.58

52 Week Range

Now: $98.45
Low: $67.88
High: $132.29

Volume

1,095 shs

Average Volume

1,998 shs

Market Capitalization

$7.39 billion

P/E Ratio

7.27

Dividend Yield

2.79%

Beta

1.4

Frequently Asked Questions

What sell-side analysts currently cover shares of Arkema?

The following Wall Street sell-side analysts have issued reports on Arkema in the last twelve months: Barclays PLC, Berenberg Bank, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., Morgan Stanley, Stifel Nicolaus, The Goldman Sachs Group, Inc., and UBS Group AG.
View the latest analyst ratings for ARKAY.

What is the current price target for Arkema?

6 Wall Street analysts have set twelve-month price targets for Arkema in the last year. Their average twelve-month price target is $104.00, suggesting a possible upside of 5.6%. Barclays PLC has the highest price target set, predicting ARKAY will reach $126.00 in the next twelve months. Credit Suisse Group AG has the lowest price target set, forecasting a price of $79.00 for Arkema in the next year.
View the latest price targets for ARKAY.

What is the current consensus analyst rating for Arkema?

Arkema currently has 2 sell ratings, 2 hold ratings and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in ARKAY, but not buy more shares or sell existing shares.
View the latest ratings for ARKAY.

What other companies compete with Arkema?

Other companies that are similar to Arkema include JFE, Mondi, Covestro, Nissan Chemical and Kimberly-Clark de México, S. A. B. de C. V.. Learn More about companies similar to Arkema.

How do I contact Arkema's investor relations team?

Arkema's physical mailing address is 420 rue d`Estienne d Orves, Colombes Cedex I0, 92700. The basic materials company's listed phone number is (314) 900-8080 and its investor relations email address is [email protected] The official website for Arkema is www.arkema.com. Learn More about contacing Arkema investor relations.